Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Gene therapy strategies for novel cancer therapeutics
Maryland E. Rosenfeld
,
David T. Curiel
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Department of Radiation Oncology
Center of Regenerative Medicine
DBBS - Developmental, Regenerative and Stem Cell Biology
DBBS - Immunology
DBBS - Molecular Microbiology and Microbial Pathogenesis
DBBS - Molecular Genetics and Genomics
Brain Tumor Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
20
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gene therapy strategies for novel cancer therapeutics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Gene Therapy
100%
Novel Therapeutics
100%
Therapy Strategy
100%
Immunopotentiating Activity
66%
Mutation Compensation
66%
Molecular Chemotherapy
66%
Gene Expression
33%
Host Immune Response
33%
Tumor Cells
33%
Ablating
33%
Molecular Genetics
33%
Tumor Suppressor Gene
33%
Oncogene
33%
Human Trials
33%
Neoplastic Disease
33%
Tumor Antigen
33%
Rapid Implementation
33%
Immune Stimulation
33%
Toxin Genes
33%
Foreign Genes
33%
Medicine and Dentistry
Malignant Neoplasm
100%
Gene Therapy
100%
Immunopotentiation
66%
Neoplasm
33%
Clinical Trial
33%
Immune Response
33%
Tumor Cell
33%
Tumor Suppressor Gene
33%
Gene Expression
33%
Oncogene
33%
Tumor Antigen
33%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Malignant Neoplasm
100%
Chemotherapy
100%
Clinical Trial
50%
Tumor Antigen
50%
Tumor Suppressor Protein
50%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Genetics
66%
Immunopotentiation
66%
Gene Expression
33%
Clinical Trial
33%
Immune Response
33%
Tumor Suppressor Gene
33%
Oncogene
33%
Tumor Antigen
33%